Exploring optimal in situ fabrication conditions to realize core–shell CsPbBr3 QDs with high PLQYs and structural stability by dual-defect passivation

Dokyum Kim , Soogeun Kim , Sang-Youp Yim and Chang-Lyoul Lee *
Advanced Photonics Research Institute (APRI), Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea. E-mail: vsepr@gist.ac.kr

Received 21st November 2024 , Accepted 8th February 2025

First published on 14th February 2025


Abstract

Core–shell CsPbBr3 QDs (core–shell M–CsPbBr3 QDs) with high structural stability and excellent optical properties were developed through dual-defect passivation, with simultaneous application of in situ thiol ligand passivation and a core–shell structure using SiO2 as a shell. When MPTES was injected immediately before Cs-oleate injection, the formation of by-products (PbS and trigonal-Cs4PbBr6 nanocrystals) was suppressed/minimized and effective surface defect passivation was achieved, resulting in defect-less core–shell M–CsPbBr3 QDs. The thiol group of MPTES effectively passivated uncoordinated Pb2+ defects, while the SiO2 shell formed by the hydrolysis reaction of three silyl ethers inhibited the formation of defects (vacancies) by preventing the penetration of moisture. The core–shell M–CsPbBr3 QDs exhibited a PLQY of ∼82.9 ± 3.8%, much higher than that of pristine CsPbBr3 QDs (∼65.3 ± 3.8%). Furthermore, they also showed more than 5 times higher structural stability in DI water compared to pristine CsPbBr3 QDs. These results demonstrated that the synergistic effect of surface passivation with the thiol group and the core–shell structure can significantly improve the PLQYs and structural stability of CsPbBr3 QDs.


Introduction

Recently, there has been intensive research on halide perovskite quantum dots (PQDs) due to their excellent optoelectronic properties.1,2 In particular, CsPbX3 QDs (X = Cl, Br, and I) have shown great potential in the fields of various optoelectronics including light-emitting diodes (LEDs),3 bio-imaging,4 and more.5 Nevertheless, CsPbX3 QDs suffer from their poor structural stability to various external stimuli, especially moisture (water), due to their ionic nature. The surface defects and vacancies generated by ligand dissociation and halide ion migration cause rapid structural degradation of the CsPbX3 QDs.6,7 This structural degradation increases non-radiative recombination and consequently reduces the optoelectronic properties, including photoluminescence quantum yields (PLQYs).8–10 Therefore, the development of methods for improving the structural stability of CsPbX3 QDs by suppressing defect formation and passivating surface defects is urgently needed for their widespread practical applications. Various methods have been proposed to improve the structural stability of CsPbX3 QDs, including metal (alkali metals, transition metals, etc.) doping,11–13 core–shell structures,14–16 and surface defect passivation such as ligand modification.17,18 Metal doping is a method in which metal ions with the same charge number and similar ionic radii occupy the A-, B-, or interstitial sites of CsPbX3 QDs.19–21 The decrease of defect density and the change in the B–X bond length lead to an improvement in the structural stability of CsPbX3 QDs.11,22

The core–shell structure also enhanced the structural stability of CsPbX3 QDs by introducing polymers or inorganic materials, especially oxide materials such as SiO2, as shell layers.5,23 The SiO2 shell layer provided environmental and chemical resistance against external stimuli (e.g. moisture, oxygen, heat, etc.) and prevented the anion exchange between CsPbX3 QDs with different halide compositions, enabling full-color displays through the stacking of red, green, and blue CsPbX3 QDs.24 The SiO2 shell could be formed either through post-treatment25–27 or an in situ process during the fabrication of CsPbX3 QDs.23,28 Core–shell CsPbBr3/SiO2 QDs were fabricated by post-treatment with tetraethyl orthosilicate (TEOS)24via a hydrolysis reaction of the silane group of TEOS in air. Despite significant improvement in structural stability, the aggregation of CsPbBr3/SiO2 QDs and the presence of multiple CsPbBr3 QDs within a single SiO2 shell should be addressed for further perovskite LED (PeLED) applications.29In situ SiO2 shell formation can address the disadvantages of the post-treatment process mentioned above. Recently, our group successfully reported the fabrication of core–shell CsPbBr3/SiO2 QDs via an in situ hot-injection process.23 3-aminopropyl-triethoxysilane (APTES), which served not only as an amine ligand but also as a precursor for SiO2 shell formation, was added during the fabrication of CsPbBr3 QDs using a modified hot-injection process. The fabricated core–shell CsPbBr3/SiO2 QDs were agglomeration-free and consisted of a single CsPbBr3 QD coated with an SiO2 shell. They also showed excellent chemical stability and high PLQYs in various polar solvents. Notably, the thickness of a SiO2 shell is ∼2–3 nm, which allowed core–shell CsPbBr3/SiO2 QDs to be applied to PeLEDs without compromising charge mobility.

Surface defect passivation using ligands with various functional groups (e.g., conjugated ligands or X-type ligands) is widely utilized to improve the structural stability of CsPbX3.30,31 Due to the low migration energy of halide ions, defects (vacancies) are easily formed, which destroy the PbX6 octahedral structure and create uncoordinated Pb2+ defects.32,33 Therefore, effective passivation of both halide defects and uncoordinated Pb2+ defects is strongly required to improve the structural stability of CsPbX3 QDs. The introduction of ligands with thiol (–SH) groups as surface passivation ligands can significantly improve the structural stability and optoelectronic properties of CsPbBr3 QDs.34–38 The thiol group loses H+ to become S, and S strongly binds to uncoordinated Pb2+ defects, effectively passivating (occupying) the halide defects and consequently healing the B- and X-site defects.34,38 Surface defect passivation using ligands with thiol groups has been performed either as a post-treatment34,39 or an in situ process.36–38 Bi et al. reported that surface defects generated by ligand dissociation during the purification of CsPbI3 QDs were successfully passivated by ligand exchange with the 2-aminoethanethiol (AET) ligand via the post-treatment process.39 In most of the reported studies, the thiol ligand exchange, which is an X-type ligand, has been performed as a post-treatment process after the fabrication of PQDs because the in situ addition of thiol ligands instead of oleic acid (OA) and oleylamine (OAm) during the fabrication of PQDs can induce size/shape changes34 and phase transitions35,36,40 due to their strong affinity for Pb2+.

Recently, an in situ passivation strategy using various thiol ligands has been reported.36,37 Yang et al. reported in situ surface defect passivation of CsPbBr3 QDs with dodecylbenzenesulfonic acid.38 This metal chelating sulfonate ligand has a strong affinity for Pb2+, which significantly enhanced the structural stability and PLQYs compared to those of CsPbBr3 QDs passivated with OA and OAm.38 This in situ passivation with a thiol ligand has the following advantages over post-treatment processes: (1) uniform particle size distribution via the fabrication of thermodynamically stable CsPbBr3 QDs using a high-affinity thiol ligand, (2) suppression of surface defect formation through strong Pb–S binding, and (3) a simple fabrication protocol. L. Ruan et al. fabricated CsPb2Br5 nanowires (NWs) and nanosheets (NSs) with high PLQYs by in situ passivation using an alkyl thiol as the surface ligand during the fabrication of NWs and NSs via a precipitation method.36 Nevertheless, the most serious problem associated with in situ thiol ligand passivation is the easy formation of PbS nanocrystals instead of halide perovskite nanocrystals due to the strong affinity of the sulfur group for Pb2+.35–37 It also induces shape changes (e.g., from zero-dimensional QDs to one- or two-dimensional NWs and NSs) and phase transitions (e.g., from orthorhombic-CsPbBr3 to tetragonal-CsPb2Br5 or trigonal-Cs4PbBr6).35–37 Therefore, an optimal synthetic protocol must be developed to perform an in situ thiol ligand passivation method that can effectively passivate surface defects in CsPbBr3 QDs while simultaneously suppressing PbS nanocrystal formation.

In this work, we have developed core–shell CsPbBr3 QDs with high structural stability and PLQYs through dual-defect passivation, with simultaneous application of in situ thiol ligand passivation and a core–shell structure using SiO2 as a shell. Most of the studies reported to date have enhanced the structural stability and optoelectronic properties of CsPbBr3 QDs by suppressing surface defect formation through in situ thiol ligand passivation and the use of a core–shell structure. To the best of our knowledge, no studies combining these two methods have been reported. The synergistic effect of two representative defect passivation/suppression methods will dramatically improve the structural stability and optoelectronic properties of CsPbBr3 QDs. (3-mercaptopropyl)triethoxysilane (MPTES) having a thiol group (–SH) and three silyl ether groups (–Si(OC2H5)3) was used as a surface passivation ligand as well as a precursor for SiO2 shell formation for dual-defect passivation (Fig. S1). The thiol group of MPTES effectively passivated uncoordinated Pb2+ defects, while the SiO2 shell formed by the hydrolysis reaction of three silyl ethers inhibited the formation of surface defects (vacancies) by preventing the penetration of moisture (water). Notably, in this work, dual-defect passivation is performed by an in situ process, rather than a post-treatment process. The in situ thiol ligand passivation of core–shell CsPbBr3 QDs (i.e., core–shell M–CsPbBr3 QDs) and the effect of dual-defect passivation on the structural stability and PLQYs of core–shell M–CsPbBr3 QDs have been investigated. In particular, the optimal fabrication conditions for core–shell M–CsPbBr3 QDs have been investigated by controlling synthetic parameters such as the MPTES injection point, the MPTES concentration (MPTES/Pb mol ratio), and the reaction time to suppress the formation of PbS and Cs4PbBr6 nanocrystals that degraded the optoelectronic properties. The crystal growth of core–shell M–CsPbBr3 QDs was governed by both thiol (MPTES) and carboxylic acid (OA) ligands when the MPTES/Pb mol ratio was less than 1.0, but was mainly dominated by the thiol ligand when the MPTES/Pb mol ratio was more than 1.0. Therefore, when MPTES with a high binding affinity for Pb2+ was used as a ligand, a long reaction time (∼20 s) was required to grow core–shell M–CsPbBr3 QDs thermodynamically rather than kinetically (∼5 s). When a high concentration of MPTES was injected after immediately degassing the Pb-pot, PbS, and trigonal-Cs4PbBr6 nanocrystals were fabricated instead of core–shell M–CsPbBr3 QDs due to the strong affinity between Pb2+ and the thiol ligand and depletion of Pb2+. However, when a high concentration of MPTES was injected immediately before Cs-oleate injection, the formation of by-products (PbS and trigonal-Cs4PbBr6 nanocrystals) was suppressed/minimized and effective surface defect passivation was achieved, resulting in defect-less core–shell M–CsPbBr3 QDs. The core–shell M–CsPbBr3 QDs exhibited excellent PLQYs and structural stability compared to pristine CsPbBr3 QDs. The core–shell M–CsPbBr3 QDs exhibited a PLQY of ∼82.9 ± 3.8%, much higher than that of pristine CsPbBr3 QDs (∼65.3 ± 3.8%). Furthermore, they also showed superior structural stability after exposure to deionized (DI) water, retaining about half of the initial PLQY (∼46.3%) after 9 h, while pristine CsPbBr3 QDs were completely quenched after 5 h. Core–shell M–CsPbBr3 QDs were found to be about 5 times more stable in DI water than pristine CsPbBr3 QDs. These results demonstrated that dual-defect passivation with MPTES significantly improved the PLQYs and structural stability of CsPbBr3 QDs, which can be applied to various optoelectronics in the future.

Experimental methods

Materials

Cesium carbonate (Cs2CO3, 99%), lead bromide (PbBr2, 98%), oleic acid (OA, 90%), oleylamine (OAm, 70%), (3-mercaptopropyl)triethoxysilane (MPTES, 80%), 1-octadecane (ODE, 90%), and toluene (99.8%) were purchased from Sigma-Aldrich. Methyl acetate (MeAc, 99%) and acetone (99.7%) were purchased from Samchun. All chemicals were used without further purification.

Fabrication of pristine CsPbBr3 QDs

For the preparation of the cesium oleate (Cs-oleate) precursor (Cs-pot), 100 mg of Cs2CO3 (0.614 mmol), 0.4 mL of OA, and 5 mL of ODE were added to a 25 mL two-neck round flask and degassed at ∼100 °C with continuous stirring under vacuum until obtaining a clear solution (∼30 min). In another 25 mL two-neck round flask (Pb-pot), 69 mg of PbBr2 (0.188 mmol), 0.5 mL of OA and 0.5 mL of OAm were dissolved in 5 mL of ODE and degassed at ∼100 °C with continuous stirring under vacuum until obtaining a clear solution (∼30 min). The Cs-pot was heated to ∼150 °C and the Pb-pot was heated to ∼180 °C with continuous stirring under N2 gas. Then, 0.4 mL of Cs-oleate was quickly injected into the Pb-pot (∼180 °C). After the reaction for ∼5 s, the mixture was cooled with ice water (crude solution). The crude solution was centrifuged with MeAc (crude solution[thin space (1/6-em)]:[thin space (1/6-em)]MeAc = 2[thin space (1/6-em)]:[thin space (1/6-em)]1, volume ratio) at 15 krpm for 5 min for purification. The precipitate was then dispersed in 2 mL of toluene and centrifuged again at 15 krpm for 5 min. The supernatant was placed in a brown vial and stored in an N2-filled glovebox.

Fabrication of core–shell M–CsPbBr3 QDs

Core–shell M–CsPbBr3 QDs were fabricated via the same synthetic procedure as pristine CsPbBr3 QDs except for the following conditions: (1) addition of a high-affinity thiol ligand, MPTES, (2) a different reaction time and (3) a different purification solvent (acetone). MPTES was injected into the Pb-pot at MPTES/Pb mol ratios ranging from 0.3 to 3.0. MPTES was injected into the Pb-pot at two different times: (1) immediately after degassing the Pb-pot and (2) immediately before Cs-oleate injection. The crude solution was prepared with a reaction time of ∼5–∼30 s and centrifuged at 15 krpm for 5 min with acetone (crude solution[thin space (1/6-em)]:[thin space (1/6-em)]acetone = 4[thin space (1/6-em)]:[thin space (1/6-em)]1, volume ratio) for ultra-thin SiO2 shell formation by a hydrolysis reaction. The crude solution was centrifuged with MeAc (crude solution[thin space (1/6-em)]:[thin space (1/6-em)]MeAc = 2[thin space (1/6-em)]:[thin space (1/6-em)]1, volume ratio) at 15 krpm for 5 min for purification. The precipitate was then dispersed in 2 mL of toluene and centrifuged again at 15 krpm for 5 min. The supernatant was placed in a brown vial and stored in an N2-filled glovebox.

Fabrication of MPTES–CsPbBr3 QDs

MPTES–CsPbBr3 QDs were fabricated via the same synthetic procedure as that of pristine CsPbBr3 QDs, except for substituting OA with MPTES (OA-free). After degassing the Pb-pot, MPTES (MPTES/Pb mol ratio of 1.0) was injected into the OA-free Pb-pot. The crude solution was prepared with a reaction time of ∼5 s and centrifuged with MeAc (crude solution[thin space (1/6-em)]:[thin space (1/6-em)]MeAc = 2[thin space (1/6-em)]:[thin space (1/6-em)]1, volume ratio) at 15 krpm for 5 min for purification. The precipitate was then dispersed in 2 mL of toluene and centrifuged again at 15 krpm for 5 min. The supernatant was placed in a brown vial and stored in an N2-filled glovebox.

Preparation of PbS nanocrystals

After degassing the Pb-pot, MPTES (MPTES/Pb mol ratios of 0.6 and 1.4) was injected into the Pb-pot, slowly heated to ∼180 °C and cooled with ice water without Cs-oleate injection. The crude solution was centrifuged with acetone (crude solution[thin space (1/6-em)]:[thin space (1/6-em)]acetone = 4[thin space (1/6-em)]:[thin space (1/6-em)]1, volume ratio) at 15 krpm for 5 min for purification. The precipitate was then dispersed in 2 mL of toluene and centrifuged again at 15 krpm for 5 min. The supernatant was placed in a brown vial and stored in an N2-filled glovebox.

Characterization

The photoluminescence (PL) spectra were recorded using a PL spectrometer system consisting of two monochromators (SP-2150i and SP-2300i, Acton), a photomultiplier tube (PMT, Acton PD471) and a xenon lamp as an excitation source. The photoluminescence quantum yields (PLQYs) were calculated relative to coumarin 500 with a PLQY of ∼47% in ethanol under 390 nm excitation.41 Absorbance spectra were recorded using a double-beam UV-Vis spectrophotometer (Mega-800, Scinco). Raman spectra were recorded using a confocal Raman system equipped with a 785 nm excitation laser (I0785SD0100B-IS, Innovative Photonic Solutions), a 100× objective lens (NA 0.9, MPLFLN, Olympus), a Czerny–Turner spectrograph (Omni-λ200i, Zolix), and a low dark current deep-depletion charge-coupled device (iVac 316, Andor Technology). The crystal structures of the PQDs were obtained using a multi-purpose X-ray diffraction (XRD) system (SmartLab, Rigaku) with Cu Kα radiation (λ = 1.5418 Å). The chemical states of the PQDs were confirmed through X-ray photoelectron spectroscopy analysis (XPS, NEXSA, Thermo Fisher Scientific). The microstructures, particle size, and elemental composition of the PQDs were determined by transmission electron microscopy (TEM, Tecnai G2 F30 S-Twin 300 kV) and energy dispersive X-ray spectroscopy (EDS, Octane Elite EDS system). Fast Fourier transform (FFT) pattern analysis was performed using Gatan Digital Micrograph software (Gatan Inc.).

Results and discussion

The fabrication of in situ core–shell M–CsPbBr3 QDs was optimized by controlling the following fabrication conditions: (1) MPTES injection time, (2) MPTES concentration (MPTES/Pb mol ratio), and (3) reaction time. Despite the high affinity of MPTES for Pb2+, the formation of PbS nanocrystals, which hindered the fabrication of core–shell M–CsPbBr3 QDs, could be suppressed by controlling the fabrication conditions mentioned above. In particular, the effect of MPTES injection time on the optical properties of core–shell M–CsPbBr3 QDs was systematically investigated. MPTES was injected into the Pb-pot at two different times during the fabrication of core–shell M–CsPbBr3 QDs: (1) immediately after degassing the Pb-pot and (2) immediately before Cs-oleate injection. It is noteworthy that the MPTES concentration (MPTES/Pb mol ratio) and reaction time, which are dependent on the MPTES injection time, were also key parameters for the fabrication of high-quality core–shell M–CsPbBr3 QDs via a modified in situ hot-injection method.

The effect of MPTES injection time and concentration (MPTES/Pb mol ratio) on the optical properties of core–shell M–CsPbBr3 QDs was investigated. Fig. 1(a)–(c) show the PL spectra, PLλmax, full width at half maximum (FWHM), and PLQYs of core–shell M–CsPbBr3 QDs as a function of MPTES concentration (MPTES/Pb mol ratio). MPTES was injected into the Pb-pot immediately after degassing the Pb-pot. The PL spectral profiles (i.e., shape and PLλmax) of core–shell M–CsPbBr3 QDs varied around an MPTES/Pb mol ratio of 1.0 (Fig. 1(a)). Broad (FWHM: ∼30 nm) and non-Gaussian-shaped PL spectra centered at ∼500 nm were observed when the MPTES/Pb mol ratios were less than 1.0, whereas narrow (FWHM: ∼22 nm) and Gaussian-shaped PL spectra were observed when they were more than 1.0. The PL shoulder peak at ∼480 nm observed at MPTES/Pb mol ratios below 1.0 disappeared as MPTES/Pb mol ratios increased above 1.0. The PL spectra of core–shell M–CsPbBr3 QDs were analyzed using the spectral deconvolution method, and the results are shown in Fig. S2. The PL spectra could be resolved into two PL peaks (PLλmax) at ∼503 nm and ∼509 nm regardless of MPTES/Pb mol ratios. These deconvolution results are consistent with the PL peak observed at ∼504 nm for MPTES–CsPbBr3 QDs using MPTES (Pb-thiolate) as a ligand instead of OA and the PL peak observed at ∼510 nm for pristine CsPbBr3 QDs using OA (Pb-oleate) as a ligand (Fig. S3). It is well known that the Pb2+ release rate determines the shape, phase, and/or size of CsPbBr3 QDs.37 The strong affinity of the thiol group for Pb2+ slowly released Pb2+ from Pb-thiolate during the fabrication of the core–shell M–CsPbBr3 QDs, causing a blue shift of the PL emission compared to pristine CsPbBr3 QDs by inhibiting the crystal growth (i.e., small particle size). As the MPTES/Pb mol ratio increased, the deconvoluted PL intensity at ∼503 nm (red square) originating from core–shell M–CsPbBr3 QDs fabricated from Pb-thiolate increased, while the deconvoluted PL intensity at ∼509 nm (blue circle) originating from pristine CsPbBr3 QDs fabricated from Pb-oleate decreased and approached zero (Fig. S2(f)). These results demonstrated that both thiol and carboxylic acid (OA) ligands could affect the crystal growth of CsPbBr3 QDs, but the thiol ligand with a strong binding affinity for Pb2+ has more impact on the crystal growth. These different Pb2+ release rates of each ligand resulted in a broad PL spectrum (broadened FWHM and/or PL peak splitting). When the thiol ligand concentration is equal to or higher than the Pb2+ concentration, the PL spectrum becomes narrow and PL emission at ∼503 nm is dominant (Fig. 1(b) and Fig. S2).


image file: d4nr04890c-f1.tif
Fig. 1 (a) PL spectra, (b) PLλmax and FWHM, (c) PLQYs, (d) XPS spectra, (e) XRD patterns and (f) absorbance spectra of core–shell M–CsPbBr3 QDs as a function of MPTES concentration (MPTES/Pb mol ratio). JCPDS card no. 01-073-2478 of trigonal-Cs4PbBr6 nanocrystals. MPTES was injected into the Pb-pot immediately after degassing the Pb-pot. Reaction time was ∼5 s.

The PLQYs of core–shell M–CsPbBr3 QDs as a function of MPTES concentration (MPTES/Pb mol ratio) are shown in Fig. 1(c). In general, the PQDs passivated with high-affinity ligands show high PLQYs and structural (chemical) stability.42 Therefore, the CsPbBr3 QDs passivated with the thiol ligand are expected to show a high PLQY, because the thiol ligand has a stronger surface binding affinity than the carboxylic acid ligand. However, contrary to expectations, core–shell M–CsPbBr3 QDs showed a much lower PLQY than pristine CsPbBr3 QDs passivated with OA. The relatively low PLQYs at MPTES/Pb mol ratios below 1.0 were attributed to insufficient surface defect passivation due to the deficiency of the thiol ligand. In addition, the steric hindrance of MPTES reduced surface defect passivation by OA, which increased defect density and consequently reduced PLQYs.19,43 On the other hand, although lower than that of pristine CsPbBr3 QDs, the PLQYs of core–shell M–CsPbBr3 QDs increased at MPTES/Pb mol ratios above 1.0, which was attributed to the passivation of uncoordinated Pb2+ defects with the S of the thiol ligand due to strong Pb–S binding at a high MPTES concentration (MPTES/Pb mol ratio). The peaks at ∼163.4 eV and ∼165.4 eV assigned to the bound thiol ligands (Pb–S binding)44 and free thiol ligands34 were observed in X-ray photoelectron spectroscopy (XPS) results (Fig. 1(d)). As the MPTES concentration (MPTES/Pb mol ratio) increased, the intensity at ∼163.4 eV, which is attributed to the bound thiol ligands, increased. These bound thiol ligands can also passivate Br defects (vacancies), resulting in an improved PLQY.30,45 Nevertheless, the formation of non-luminescent trigonal-Cs4PbBr6 nanocrystals hindered further PLQY enhancement in core–shell M–CsPbBr3 QDs at MPTES/Pb mol ratios above 1.0. The strong and selective affinity of the thiol group for Pb2+ led to the depletion of Pb2+ during the fabrication of CsPbBr3 QDs, resulting in the fabrication of trigonal-Cs4PbBr6 nanocrystals.37 The presence of trigonal-Cs4PbBr6 nanocrystals was confirmed by the X-ray diffraction (XRD) pattern and the absorbance spectra (Fig. 1(e) and (f)). The peaks at ∼12.6° and ∼12.9° assigned to the (012) and (110) planes of trigonal-Cs4PbBr6 nanocrystals (JCPDS no. 01-073-2478)37 and the peak at ∼313 nm (ref. 35) were observed, respectively.

Notably, the concentration of trigonal-Cs4PbBr6 nanocrystals increased with increasing MPTES concentration (MPTES/Pb mol ratio) (Fig. 1(e) and (f)), but the crystal structure of the core–shell M–CsPbBr3 QDs remained an orthorhombic structure regardless of the concentration of MPTES (Fig. S4). These results demonstrated that the depletion of Pb2+ during the fabrication of core–shell M–CsPbBr3 QDs is affected by the MPTES concentration (MPTES/Pb mol ratio), but could potentially be suppressed by controlling the reaction time of Pb2+ and S by changing the MPTES injection time. Therefore, to suppress the formation of non-luminescent trigonal-Cs4PbBr6 nanocrystals, the optimal MPTES injection time at a high thiol ligand concentration should be investigated to minimize the depletion of Pb2+.

As discussed earlier, the strong affinity of the thiol group for Pb2+ readily formed PbS nanocrystals, which prevented the Pb2+ precursor from being used for the formation of CsPbBr3 QDs. In particular, PbS nanocrystals formed more efficiently at high concentrations of the thiol ligand due to high S (sulfur) concentration. The formation of PbS nanocrystals must be suppressed because it not only interrupted the fabrication of CsPbBr3 QDs but also degraded the optical properties and structural stability of CsPbBr3 QDs. Therefore, it is necessary to investigate in detail why and when the formation of PbS nanocrystals and the depletion of Pb2+ occur. Gurin et al. reported that when the PbS nanocrystals grow from Pb2+ and thiols in the solution, the color of the solution changes from yellow to light brown or black.46 When MPTES was injected immediately after degassing the Pb-pot, the color of the Pb-pot changed from yellow to brown or dark brown, indicating the formation of PbS nanocrystals. The color of the Pb-pot became darker (brown to dark brown) as the MPTES concentration (MPTES/Pb mol ratio) increased (Movies S1 and S2). The transparent solution in the Pb-pot slowly changed when MPTES with a ratio of 0.6 to Pb2+ (Movie S1) was injected, whereas it turned dark brown immediately after MPTES with a ratio of 1.4 to Pb2+ (Movie S2) was injected.

The formation of PbS nanocrystals was also confirmed by XPS, XRD, and UV-Vis analysis results. The intensity of the Pb–S binding (bound thiol ligands) peak at ∼163.4 eV increased with increasing MPTES concentration (MPTES/Pb mol ratio) in the absence of Cs-oleate injection (Fig. 2(a)). Since the Pb–S binding peak at ∼163.4 eV came from both the passivation of uncoordinated Pb2+ defects (positive effect) and PbS nanocrystals (negative effect), the origin of the Pb–S peak needs to be confirmed by other analytical methods. The XRD pattern and UV-Vis absorbance showed that PbS nanocrystals formed with increasing MPTES concentration (MPTES/Pb mol ratio) (Fig. 2(b) and (c)). At a high MPTES concentration (MPTES/Pb mol ratio of 1.4), diffraction peaks corresponding to the (111) and (200) lattice planes at ∼26.0° and ∼30.1° were observed (JCPDS no. 00-005-0592), whereas at a low MPTES concentration (MPTES/Pb mol ratio of 0.6), no diffraction peaks were observed for PbS nanocrystals. Furthermore, the absorbance peak at ∼945 nm demonstrated the presence of PbS nanocrystals at a high MPTES concentration (MPTES/Pb mol ratio).47 These results suggested that the Pb–S binding peak at ∼163.4 eV (Fig. 2(a)) originated from both PbS nanocrystals and the passivation of uncoordinated Pb2+ defects, but the contribution of PbS nanocrystals became larger as the MPTES concentration (MPTES/Pb mol ratio) increased. The presence of PbS nanocrystals induced depletion of Pb2+ in the Pb-pot during the fabrication of core–shell M–CsPbBr3 QDs, leading to the formation of non-luminescent trigonal-Cs4PbBr6 nanocrystals.


image file: d4nr04890c-f2.tif
Fig. 2 (a) XPS spectra, (b) XRD patterns, and (c) absorbance spectra of PbS nanocrystals in the absence of Cs-oleate injection fabricated at different MPTES concentrations (MPTES/Pb mol ratio). JCPDS card no. 00-005-0592 of PbS. MPTES was injected into the Pb-pot immediately after degassing the Pb-pot. Reaction time was ∼5 s.

To suppress/minimize the formation of undesirable by-products (PbS and trigonal-Cs4PbBr6 nanocrystals), a pre-mixed solution (MPTES and Cs-oleate) prepared by adding MPTES to the Cs-pot was injected into the Pb-pot. This method is expected to reduce the interaction between the thiol group and Pb2+. The Cs-oleate solution without MPTES was transparent, while the Cs-oleate solution with MPTES was slightly opaque at 150 °C (Fig. S5(a) and (b)). This is speculated to be because Cs (an alkali metal), which acts as a catalyst, induces cross-linking of the silyl ether of MPTES to form a Si–O–Si matrix.48–50 This is further confirmed by the following results. When the Cs-pot without MPTES was cooled to room temperature (RT), the Cs-oleate was precipitated as a salt. The precipitated Cs-oleate is insoluble in ODE at RT, so the solution can flow. However, when the Cs-pot with MPTES was cooled to RT, cross-linking and gelation occurred, resulting in significantly higher viscosity that impeded flow (Fig. S5(c) and (d)). Therefore, it is difficult to expect the desired functionality from both thiol and silyl ether groups in the pre-mixed solution. In contrast to the optimal fabrication conditions, under which MPTES was added to the Pb-pot, the core–shell M–CsPbBr3 QDs fabricated using the pre-mixed solution (MPTES and Cs-oleate) showed excessively cross-linked aggregates (Si–O–Si matrix), as shown in Fig. S5(e). From these results, the use of the pre-mixed solution of MPTES and Cs-oleate is not considered as the appropriate method for the passivation of Pb2+ defects with the thiol group of MPTES. In addition, the thiol group reacts or binds with Cs+ in Cs-oleate solution, which slows down the formation of Pb-thiolate via a reaction with the Pb2+ precursor in the Pb-pot, resulting in poor Pb2+ defect passivation. Therefore, when a high concentration of the thiol ligand is used, the interaction between Pb2+ and the thiol ligand has to be reduced to minimize the formation of PbS nanocrystals, thus preventing depletion of Pb2+, which is responsible for the formation of non-luminescent trigonal-Cs4PbBr6 nanocrystals.

Fig. 3(a)–(c) show the XRD patterns and absorbance spectra of core–shell M–CsPbBr3 QDs fabricated at different MPTES injection times. As mentioned above, when MPTES was injected into the Pb-pot after immediately degassing the Pb-pot, trigonal-Cs4PbBr6 nanocrystals were formed. However, the XRD peaks and absorbance peaks of trigonal-Cs4PbBr6 nanocrystals were barely observed when MPTES was injected into the Pb-pot immediately before Cs-oleate injection under the same fabrication conditions (MPTES/Pb mol ratio of 1.4 and ∼5 s reaction time). Furthermore, the color of the Pb-pot remained yellow until the core–shell M–CsPbBr3 QDs were fabricated (Fig. 3(d)). These results demonstrated that no or little depletion of Pb2+ occurred during the fabrication of core–shell M–CsPbBr3 QDs despite MPTES being used as a ligand. By optimizing the MPTES injection time (i.e., MPTES injection immediately before Cs-oleate injection) to reduce the interaction between Pb2+ and the thiol ligand, core–shell M–CsPbBr3 QDs with high PLQYs can be fabricated by suppressing the formation of PbS and non-luminescent trigonal-Cs4PbBr6 nanocrystals and passivating uncoordinated Pb2+ defects.


image file: d4nr04890c-f3.tif
Fig. 3 (a) XRD patterns, (b) magnified view in a range of 10° to 15°, and (c) absorbance spectra of core–shell M–CsPbBr3 QDs with different MPTES injection times. Core–shell M–CsPbBr3 QDs were fabricated under the same fabrication conditions (MPTES/Pb mol ratio of 1.4 and reaction time of ∼5 s) except for different MPTES injection times. The core–shell M–CsPbBr3 QDs showed an orthorhombic crystal structure (JCPDS card no. 98-009-7851). (d) Digital photograph of the Pb-pot after MPTES injection. MPTES (MPTES/Pb mol ratio of 1.4) was injected into the Pb-pot immediately before Cs-oleate injection.

The optical properties of core–shell M–CsPbBr3 QDs fabricated by injecting MPTES immediately before Cs-oleate injection were investigated. Fig. 4(a)–(c) show the PL properties (PL spectra, PLλmax, FWHM, and PLQYs) of core–shell M–CsPbBr3 QDs as a function of the reaction time under the fabrication conditions where the MPTES/Pb mol ratio was fixed at 1.4. Unlike pristine CsPbBr3 QDs, the core–shell M–CsPbBr3 QDs fabricated with a reaction time of ∼5 s showed a non-Gaussian-shaped PL spectrum consisting of two peaks at ∼480 nm and ∼504 nm (Fig. 4(a) and S6(a)). The PL shoulder peak at ∼480 nm is speculated to be due to the formation of CsPbBr3 QDs with a small particle size, which is commonly observed under unoptimized fabrication conditions (e.g., precursor ratio, reaction time, temperature, etc.).23,51–53 The high affinity of the thiol group for Pb2+ caused slow nucleation and crystal growth during the fabrication of CsPbBr3 QDs using MPTES as the ligand. The slow surface ligand dissociation rate of MPTES delayed the adsorption of the precursor, allowing core–shell M–CsPbBr3 QDs to be grown thermodynamically rather than kinetically. The PL peak at ∼505 nm is direct evidence for core–shell M–CsPbBr3 QDs fabricated using the thiol ligand, which is dominated by slow crystal growth (Fig. S6(b)).


image file: d4nr04890c-f4.tif
Fig. 4 (a) PL spectra, (b) PLλmax and FWHM and (c) PLQYs of core–shell M–CsPbBr3 QDs as a function of reaction time. The MPTES concentration (MPTES/Pb mol ratio) was fixed at 1.4. (d) PL spectra, (e) PLλmax and FWHM and (f) PLQYs of core–shell M–CsPbBr3 QDs as a function of the MPTES concentration (MPTES/Pb mol ratio). The reaction time was fixed at ∼20 s except for pristine CsPbBr3 QDs (∼5 s). In both experiments, MPTES was injected into the Pb-pot immediately before Cs-oleate injection.

The absence of the Pb–S binding peak (∼163.4 eV) in the core–shell M–CsPbBr3 QDs fabricated at a reaction time of ∼5 s demonstrated that the uncoordinated Pb2+ defects were not efficiently passivated by the bound thiol ligands (Fig. S7). Consequently, the core–shell M–CsPbBr3 QDs fabricated at a reaction time of ∼5 s resulted in a lower PLQY (∼40.4 ± 3.9%) compared to pristine CsPbBr3 QDs (∼65.3 ± 3.8%) (Fig. 4(c)). The long reaction time (∼20 s) increased the binding probability between Pb2+ and the thiol ligand, which improved the optical properties of core–shell M–CsPbBr3 QDs by passivating surface defects with thiol ligands (Fig. 4(c) and Fig. S7). Furthermore, as the reaction time increased from ∼5 s to ∼20 s, the FWHM of core–shell M–CsPbBr3 QDs also decreased from ∼28 nm to ∼20 nm (Fig. 4(b)). The uniform particle size of core–shell M–CsPbBr3 QDs due to thermodynamic crystal growth is responsible for this narrow FWHM. In addition, the PL shoulder peak at ∼480 nm observed at a reaction time of ∼5 s completely disappeared at ∼20 s (Fig. S6), resulting in a Gaussian-shaped PL spectrum. This suggested that the fabrication conditions for the core–shell M–CsPbBr3 QDs were optimized by increasing the reaction time. As the reaction time increased, the PLQYs of core–shell M–CsPbBr3 QDs gradually increased, reaching a maximum value of ∼64.7 ± 3.7% at a reaction time of ∼20 s, which is comparable to or slightly lower than that of pristine CsPbBr3 QDs (65.3 ± 3.8%) (Fig. 4(c)). Note that the MPTES/Pb mol ratio was fixed at 1.4 in these experiments. The PLQYs of core–shell M–CsPbBr3 QDs can be further improved by optimization of the MPTES/Pb mol ratio.

Fig. 4(d)–(f) show the PL properties (PL spectra, PLλmax, FWHM, and PLQYs) of core–shell M–CsPbBr3 QDs as a function of the MPTES concentration (MPTES/Pb mol ratio) under the fabrication conditions where the reaction time was fixed at ∼20 s. Unlike the core–shell M–CsPbBr3 QDs fabricated with a reaction time of ∼5 s, no PL shoulder peak at ∼480 nm was observed for the core–shell M–CsPbBr3 QDs fabricated with a reaction time of ∼20 s for all MPTES concentrations (MPTES/Pb mol ratios) (Fig. 4(d)). The PLλmax and FWHM of all core–shell M–CsPbBr3 QDs exhibited similar values of ∼506 nm (∼507 nm for an MPTES/Pb mol ratio of 3.0) and ∼20 nm, respectively (Fig. 4(e)). The narrow FWHM of core–shell M–CsPbBr3 QDs (∼20 nm) enables excellent color purity in LED applications. The highest PLQY of 82.9 ± 3.8% was achieved at an MPTES/Pb mol ratio of 2.4. Under these fabrication conditions, the color of the Pb-pot did not turn brown and remained yellow until the core–shell M–CsPbBr3 QDs were fabricated (Movie S3), indicating that the formation of PbS nanocrystals did not occur, which is responsible for the formation of non-luminescent trigonal-Cs4PbBr6 nanocrystals by depletion of Pb2+. However, at an MPTES/Pb mol ratio of 3.0, the PLQY slightly decreased, which was attributed to the depletion of Pb2+ in the Pb-pot due to the high concentration of MPTES, as mentioned above. Fig. S8 shows that trigonal-Cs4PbBr6 nanocrystals precipitated in a crude solution with an MPTES/Pb mol ratio of 3.0 and a reaction time of ∼20 s.

Fig. S9 summarizes the effect of synthetic parameters (MPTES injection time, MPTES concentration (MPTES/Pb mol ratio), and reaction time) on the optical properties of core–shell M–CsPbBr3 QDs. The crystal growth of core–shell M–CsPbBr3 QDs was governed by both thiol (MPTES) and carboxylic acid (OA) ligands when the MPTES/Pb mol ratio was less than 1.0, but was mainly dominated by the thiol ligand when the MPTES/Pb mol ratio was more than 1.0. In general, CsPbBr3 QDs kinetically grew when a carboxylic acid (OA) with a weak binding affinity for Pb2+ was used as a ligand. On the other hand, when MPTES, which has a high binding affinity for Pb2+, was used as a ligand, CsPbBr3 QDs were more favorable to grow thermodynamically, thus requiring a longer reaction time (∼20 s) than kinetically grown QDs (∼5 s). The thermodynamic crystal growth suppressed the formation of defects, which enabled the implementation of high-quality CsPbBr3 QDs. The MPTES injection time has a significant effect on the optical properties of core–shell M–CsPbBr3 QDs. When a high concentration of MPTES (MPTES/Pb mol ratio was larger than 1.0) was immediately injected after degassing the Pb-pot, non-luminescent trigonal-Cs4PbBr6 nanocrystals were fabricated instead of core–shell M–CsPbBr3 QDs, which was attributed to the depletion of Pb2+ by the formation of PbS nanocrystals due to the strong affinity between Pb2+ and the thiol ligand. However, when a high concentration of MPTES was injected immediately before Cs-oleate injection, the formation of by-products (PbS and trigonal-Cs4PbBr6 nanocrystals) was suppressed/minimized and effective surface defect passivation was achieved, resulting in defect-less core–shell M–CsPbBr3 QDs. These results demonstrated that systematic control of synthetic parameters (concentration and injection time of the thiol ligand, reaction time, etc.) is necessary to ensure superior optical and structural stability of CsPbBr3 QDs fabricated by a modified in situ hot-injection method using the thiol ligand rather than conventional OA.

The introduction of inorganic shells (e.g., SiO2) into CsPbBr3 QDs can significantly improve their structural stability against environmental stimuli (moisture, oxygen, light, etc.) without deterioration of the optoelectronic properties. MPTES not only acts as a ligand to passivate surface defects (Pb2+ and Br defects) but can also act as a precursor for SiO2 shell formation. The thiol group (–SH) effectively passivated the surface defects, and three silyl ether groups formed a cross-linked Si–O–Si matrix coating each CsPbBr3 QD through a hydrolysis reaction.19,54 The silyl ether groups of MPTES reacted with polar media (e.g., acetone and methyl acetate) during the purification process to form a Si–O–Si matrix (SiO2 shell), which was coated on the surfaces of CsPbBr3 QDs. The chemical reactions for the formation of an SiO2 shell are described below.

 
–SiOC2H5 + H2O → –SiOH + C2H5OH(1)
 
–SiOH + –SiOC2H5 → –SiOSi– + C2H5OH(2)
 
–SiOH + –SiOH → –SiOSi– + H2O.(3)

The high-resolution transmission electron microscopy (HR-TEM) image of core–shell M–CsPbBr3 QDs in Fig. 5(c) confirmed the presence of an ultra-thin SiO2 shell with a thickness of ∼1–2 nm, which was not observed in the HR-TEM image of the pristine CsPbBr3 QDs (Fig. 5(a)). The transmission electron microscopy-energy dispersive spectroscopy (TEM-EDS) analysis further confirmed the presence of an SiO2 shell on the surfaces of CsPbBr3 QDs (Fig. S10). The scanning transmission electron microscopy (STEM) image (Fig. S10(a)) shows the location where TEM-EDS line scanning was performed to analyze the composition of core–shell M–CsPbBr3 QDs. Since the long analysis time of TEM-EDS line scanning can lead to the degradation of core–shell M–CsPbBr3 QDs, TEM-EDS line scanning was performed at low magnification rather than at high magnification to obtain reliable measurement results. Si and O were detected together in the region where the core–shell M–CsPbBr3 QDs were clustered (Fig. S10(c)–(e) and Table S1). From the TEM-EDS results, it is demonstrated that the SiO2 shell was successfully coated on the surfaces of CsPbBr3 QDs. The TEM results also showed that a single CsPbBr3 QD was coated with an SiO2 shell, rather than multiple CsPbBr3 QDs embedded in an SiO2 shell22,53 and core–shell M–CsPbBr3 QDs exhibited a well-ordered morphology without aggregation (Fig. S10(b)).


image file: d4nr04890c-f5.tif
Fig. 5 (a)–(c) HR-TEM images of (a) pristine CsPbBr3 QDs, (b) shell-less M–CsPbBr3 QDs, and (c) core–shell M–CsPbBr3 QDs. MPTES was injected into the Pb-pot immediately before Cs-oleate injection. The MPTES concentration (MPTES/Pb mol ratio) was fixed at 2.4 and the reaction time was fixed at ∼20 s. The inset shows fast Fourier transform (FFT) images. The chemical/environmental stabilities of pristine CsPbBr3 QDs, shell-less M–CsPbBr3 QDs, and core–shell M–CsPbBr3 QDs (d) immersed in DI water and (e) exposed to ambient air.

The Raman spectra also proved the presence of the SiO2 shell (Fig. S11(a)). A Raman peak at ∼1143 cm−1, attributed to Si–O–Si stretching,55 was observed in the core–shell M–CsPbBr3 QDs, which was not observed in the pristine CsPbBr3 QDs. In addition, the Raman peak at ∼1119 cm−1 corresponding to the Si–O–C stretching56 is attributed to the unhydrolyzed silyl ether groups of MPTES attached to the surfaces of core–shell M–CsPbBr3 QDs. Shell-less M–CsPbBr3 QDs were fabricated under the same fabrication conditions, except that only methyl acetate (MeAc) was used as a purification solvent. As shown in the HR-TEM image (Fig. 5(b)), a negligibly thin SiO2 shell was formed on the surfaces of the CsPbBr3 QDs. The Raman peak at ∼1119 cm−1 (Si–O–Si) was observed, while the Raman peak at ∼1143 cm−1 (Si–O–C) was weakly observed (Fig. S11(a)). This is due to the relatively low polarity of MeAc compared to acetone, which makes the hydrolysis reaction less efficient. Furthermore, the XPS spectra showed that the intensity of the Si 2p (∼102.4 eV) peak increased gradually as the SiO2 shell was formed (Fig. S11(b)).

The d-spacing values of the three CsPbBr3 QDs (pristine/shell-less/core–shell) were obtained from the fast Fourier transform (FFT) analysis of the HR-TEM images, and the results are shown in the insets of Fig. 5. The d-spacings of shell-less and core–shell M–CsPbBr3 QDs are ∼2.93, ∼4.14, and ∼5.87 Å, corresponding to the (040), (121), and (020) planes, respectively, which are similar to those of pristine CsPbBr3 QDs (∼2.95, ∼4.18, and ∼5.91 Å corresponding to the (040), (121), and (020) planes, respectively). In addition, the XRD patterns showed that the three CsPbBr3 QDs exhibited an orthorhombic crystal structure (JCPDS no. 98-009-7851) (Fig. S11(c)). These results suggested that no significant crystal structure transition occurred in CsPbBr3 QDs after surface passivation by Pb–S binding and/or ultra-thin SiO2 shell formation.

Fig. S12 shows the TEM images and the size distribution of the three CsPbBr3 QDs. The three CsPbBr3 QDs showed a uniform cube-like shape in the TEM images. The average particle sizes of the shell-less and core–shell M–CsPbBr3 QDs were ∼9.64 and ∼9.71 nm, respectively, which were ∼1 nm smaller than that of the pristine CsPbBr3 QDs (∼10.73 nm). The particle sizes of core–shell and shell-less M–CsPbBr3 QDs were expressed simply as the size of the core (CsPbBr3 QDs) without considering the SiO2 shell thickness to ensure the accuracy of the particle size. It is consistent with the slight blue shift of the PL peaks (from ∼510 to ∼506 nm) in Fig. 4(e). The slightly smaller particle sizes of core–shell and shell-less M–CsPbBr3 QDs are attributed to the slow crystal growth due to the strong affinity of the thiol group for Pb2+ compared to OA. The relative standard deviation (RSD) of the particle size distribution of shell-less and core–shell M–CsPbBr3 QDs was reduced by about ∼4% compared to that of pristine CsPbBr3 QDs, enabling high-purity displays with a narrow FWHM.

The chemical/environmental stabilities of the three CsPbBr3 QDs (pristine/shell-less/core–shell) were investigated. Fig. 5(d) and (e) show the PL intensity variation of the three CsPbBr3 QDs in response to external stimuli: (1) immersion in DI water (CsPbBr3 QD solutions were mixed with 20 vol% DI water) and (2) exposure to ambient air. The PL intensity of the three CsPbBr3 QDs gradually decreased as the time of exposure to DI water increased. However, the PL intensity decreased in the order of core–shell M–CsPbBr3 QDs, shell-less M–CsPbBr3 QDs, and pristine CsPbBr3 QDs (Fig. 5(d) and Fig. S13). The pristine CsPbBr3 QDs maintained about half of the initial PL intensity (∼57.7%) after 1 hour and were completely quenched after 5 hours. Unlike pristine CsPbBr3 QDs, the core–shell M–CsPbBr3 QDs retained half of the initial PL intensity (∼46.3%) even after about 9 hours and were not completely quenched after even 14 hours. The PL quenching of shell-less M–CsPbBr3 QDs proceeded at a rate intermediate between those of pristine CsPbBr3 QDs and core–shell M–CsPbBr3 QDs (∼43.3% reduction from initial PL intensity after about 3 h). The structural stability of core–shell M–CsPbBr3 QDs in DI water was improved by at least 5 times compared to that of pristine CsPbBr3 QDs. The PL quenching trends of the three CsPbBr3 QDs upon air exposure were similar to those observed under DI water exposure (Fig. 5(e) and Fig. S14). When pristine CsPbBr3 QDs were exposed to ambient air, PL was almost quenched after 30 days. On the other hand, the structural stability of core–shell M–CsPbBr3 QDs upon air exposure was significantly improved compared to that of pristine CsPbBr3 QDs. When exposed to ambient air for 30 days, the PL intensity only decreased by ∼40% of the initial PL intensity. This result demonstrated that the thiol group and core–shell structure significantly enhanced the structural stability of CsPbBr3 QDs against external stimuli (moisture, oxygen, light, etc.) through uncoordinated Pb2+ defect passivation and the prevention of moisture penetration. This result is consistent with previous studies, in which the environmental stability of PQDs was significantly improved by surface defect passivation with the thiol ligand and the introduction of an SiO2 shell.23,30,38,39 The work is expected to contribute significantly to future optoelectronic applications that require high structural stability and PLQYs, such as PeLEDs, bio-imaging, and gas sensors.

Conclusions

In this work, we have developed core–shell M–CsPbBr3 QDs with high structural stability and excellent optical properties by simultaneously applying in situ thiol ligand passivation and a core–shell structure using SiO2 as a shell. (3-mercaptopropyl)triethoxysilane (MPTES) with a thiol group (–SH) and three silyl ethers (–Si(OC2H5)3) was used as a surface passivation ligand as well as a precursor for SiO2 shell formation for dual-defect passivation. The thiol group of MPTES effectively passivated uncoordinated Pb2+ defects; however, unintentional by-products (PbS and trigonal-Cs4PbBr6 nanocrystals) were also fabricated instead of core–shell M–CsPbBr3 QDs due to the strong affinity between Pb2+ and the thiol ligand. The formation of by-products was suppressed/minimized and effective surface defect passivation was achieved through systematic control of synthetic parameters (concentration and injection time of the thiol ligand, reaction time, etc.). The high affinity of the thiol group for Pb2+ slowly released Pb2+ from Pb-thiolate, causing slow crystal growth during the fabrication of core–shell M–CsPbBr3 QDs. Therefore, a high concentration of MPTES and a long reaction time (∼20 s) are required to ensure that the crystal growth of core–shell M–CsPbBr3 QDs is dominated by the thiol ligand and follows a thermodynamic rather than a kinetic reaction (∼5 s). The long reaction time (∼20 s) increased the binding probability between Pb2+ and the thiol ligand, which improved the optical properties of core–shell M–CsPbBr3 QDs by passivating uncoordinated Pb2+ defects with thiol ligands. The injection time of MPTES should be delayed (immediately before Cs-oleate injection) to reduce interaction with Pb2+, thereby inhibiting the formation of PbS and trigonal-Cs4PbBr6 nanocrystals, which interrupt the formation of core–shell M–CsPbBr3 QDs. The core–shell M–CsPbBr3 QDs exhibited excellent optical properties and structural stability compared to pristine CsPbBr3 QDs. The core–shell M–CsPbBr3 QDs exhibited a high PLQY of ∼82.9 ± 3.8% and a narrow FWHM of ∼20 nm compared to pristine CsPbBr3 QDs (∼65.3 ± 3.8% and ∼23 nm). Furthermore, they also showed higher structural stability against external stimuli (moisture, oxygen, light, etc.). In particular, core–shell M–CsPbBr3 QDs retained approximately half of the initial PL intensity after 9 hours of immersion in DI water. These results demonstrated that dual-defect passivation with MPTES can significantly improve the PLQYs and structural stability of CsPbBr3 QDs by passivating surface defects and preventing the penetration of moisture (water).

Data availability

The data supporting this article have been included as part of the ESI.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (NRF-2022R1A2C1010773 and RS-2024-00357495).

References

  1. Y. Zhou and Y. Zhao, Energy Environ. Sci., 2019, 12, 1495–1511 RSC.
  2. K. K. Chan, D. Giovanni, H. He, T. C. Sum and K.-T. Yong, ACS Appl. Nano Mater., 2021, 4, 9022–9033 CrossRef CAS.
  3. H. C. Yoon, H. Kang, S. Lee, J. H. Oh, H. Yang and Y. R. Do, ACS Appl. Mater. Interfaces, 2016, 8, 18189–18200 CrossRef CAS PubMed.
  4. P. Kumar, M. Patel, C. Park, H. Han, B. Jeong, H. Kang, R. Patel, W.-G. Koh and C. Park, J. Mater. Chem. B, 2020, 8, 10337–10345 RSC.
  5. C. Zhang, J. Chen, L. Kong, L. Wang, S. Wang, W. Chen, R. Mao, L. Turyanska, G. Jia and X. Yang, Adv. Funct. Mater., 2021, 31, 2100438 CrossRef CAS.
  6. G. Almeida, I. Infante and L. Manna, Science, 2019, 364, 833–834 CrossRef CAS PubMed.
  7. B. Rivkin, P. Fassl, Q. Sun, A. D. Taylor, Z. Chen and Y. Vaynzof, ACS Omega, 2018, 3, 10042–10047 CrossRef CAS PubMed.
  8. M. Z. Rahaman, S. Ge, C.-H. Lin, Y. Cui and T. Wu, Small Struct., 2021, 2, 2000062 CrossRef CAS.
  9. D. Huang, J. Bo, R. Zheng, C. Luo, X. Sun, Q. Li, D. Shen, Z. Zheng, M. Chen and Y. Yang, Adv. Opt. Mater., 2021, 9, 2100474 CrossRef CAS.
  10. C. Jo, D. Kim, C.-L. Lee and D.-K. Ko, Opt. Express, 2023, 31, 40352–40365 CrossRef CAS PubMed.
  11. S. Zou, Y. Liu, J. Li, C. Liu, R. Feng, F. Jiang, Y. Li, J. Song, H. Zeng and M. Hong, J. Am. Chem. Soc., 2017, 139, 11443–11450 CrossRef CAS PubMed.
  12. Y. Yang, Y. Li, W. Gong, H. Guo and X. Niu, Colloids Surf., A, 2023, 663, 131083 CrossRef CAS.
  13. B. Roy, S. Mahato, S. Bose, A. Ghorai, S. K. Srivastava, N. C. Das and S. K. Ray, Chem. Mater., 2023, 35, 1601–1609 CrossRef CAS.
  14. F. Zhang, Z. Shi, S. Li, Z. Ma, Y. Li, L. Wang, D. Wu, Y. Tian, G. Du and X. Li, ACS Appl. Mater. Interfaces, 2019, 11, 28013–28022 CrossRef CAS PubMed.
  15. H. Dong, H. Zhao, T. Xuan, W. Bai, T. Lin, Y. Cai and R.-J. Xie, ACS Appl. Mater. Interfaces, 2023, 15, 29297–29307 CrossRef CAS PubMed.
  16. Y. Cai, Y. Yang, H. Dong, T. Xuan, X. Tang and R.-J. Xie, J. Mater. Chem. C, 2023, 11, 9486–9494 RSC.
  17. Y. Liu, X. Shao, Z. Gao, Q. Xie, Y. Ying, X. Zhu, Z. Pan, J. Yang, H. Lin and X. Tang, Small, 2024, 20, 2305664 CrossRef CAS PubMed.
  18. Z. Zeng, Y. Meng, Z. Yang, Y. Ye, Q. Lin, Z. Meng, H. Hong, S. Ye, Z. Cheng and Q. Lan, ACS Appl. Mater. Interfaces, 2024, 16(8), 10389–10397 CrossRef CAS PubMed.
  19. X. Tang, W. Chen, Z. Liu, J. Du, Z. Yao, Y. Huang, C. Chen, Z. Yang, T. Shi and W. Hu, Small, 2019, 15, 1900484 CrossRef PubMed.
  20. M. T. Hoang, A. S. Pannu, C. Tang, Y. Yang, N. D. Pham, K. Gui, X. Wang, S. Yambem, P. Sonar and A. Du, Adv. Opt. Mater., 2020, 8, 2000742 CrossRef CAS.
  21. D. Kim, Y.-R. Jo, S. Kim, S.-Y. Yim, J.-H. Lee and C.-L. Lee, J. Mater. Chem. C, 2024, 12, 6395–6405 RSC.
  22. A. Swarnkar, W. J. Mir and A. Nag, ACS Energy Lett., 2018, 3, 286–289 CrossRef CAS.
  23. C. K. Trinh, H. Lee, M. G. So and C.-L. Lee, ACS Appl. Mater. Interfaces, 2021, 13, 29798–29808 CrossRef CAS PubMed.
  24. F. Gao, W. Yang, X. Liu, Y. Li, W. Liu, H. Xu and Y. Liu, Chem. Eng. J., 2021, 407, 128001 CrossRef CAS.
  25. C. Collantes, V. G. Pedro, M.-J. Banuls and A. Maquieira, ACS Appl. Nano Mater., 2021, 4, 2011–2018 CrossRef CAS PubMed.
  26. C. Collantes, W. Teixeira, V. González-Pedro, M.-J. Bañuls, P. Quintero-Campos, S. Morais and Á. Maquieira, Dalton Trans., 2023, 52, 18464–18472 RSC.
  27. C. Rossi, R. Scarfiello, R. Brescia, L. Goldoni, G. Caputo, L. Carbone, D. Colombara, L. De Trizio, L. Manna and D. Baranov, Chem. Mater., 2021, 34, 405–413 CrossRef.
  28. W. Song, Y. Wang, B. Wang, Y. Yao, W. Wang, J. Wu, Q. Shen, W. Luo and Z. Zou, Nano Res., 2020, 13, 795–801 CrossRef CAS.
  29. Q. Zhong, M. Cao, H. Hu, D. Yang, M. Chen, P. Li, L. Wu and Q. Zhang, ACS Nano, 2018, 12, 8579–8587 CrossRef CAS PubMed.
  30. S. Park, H. Cho, W. Choi, H. Zou and D. Y. Jeon, Nanoscale Adv., 2019, 1, 2828–2834 RSC.
  31. G. Li, J. Huang, H. Zhu, Y. Li, J.-X. Tang and Y. Jiang, Chem. Mater., 2018, 30, 6099–6107 CrossRef CAS.
  32. H. Wu, J. Qiu, J. Wang, Y. Wen, Q. Wang, Z. Long, D. Zhou, Y. Yang and D. Wang, Inorg. Chem. Front., 2021, 8, 658–668 RSC.
  33. X. Chen, Z. Sun, B. Cai, X. Li, S. Zhang, D. Fu, Y. Zou, Z. Fan and H. Zeng, Adv. Funct. Mater., 2022, 32, 2112129 CrossRef CAS.
  34. L. Ruan, W. Shen, A. Wang, Q. Zhou, H. Zhang and Z. Deng, Nanoscale, 2017, 9, 7252–7259 RSC.
  35. Z. Liu, Y. Bekenstein, X. Ye, S. C. Nguyen, J. Swabeck, D. Zhang, S.-T. Lee, P. Yang, W. Ma and A. P. Alivisatos, J. Am. Chem. Soc., 2017, 139, 5309–5312 CrossRef CAS PubMed.
  36. L. Ruan, W. Shen, A. Wang, A. Xiang and Z. Deng, J. Phys. Chem. Lett., 2017, 8, 3853–3860 CrossRef CAS PubMed.
  37. A. Dutta, R. K. Behera and N. Pradhan, ACS Energy Lett., 2019, 4, 926–932 CrossRef CAS.
  38. D. Yang, X. Li, W. Zhou, S. Zhang, C. Meng, Y. Wu, Y. Wang and H. Zeng, Adv. Mater., 2019, 31, 1900767 CrossRef PubMed.
  39. C. Bi, S. V. Kershaw, A. L. Rogach and J. Tian, Adv. Funct. Mater., 2019, 29, 1902446 CrossRef.
  40. S. K. Dutta, S. Bera, S. Sen and N. Pradhan, ACS Energy Lett., 2022, 7, 773–777 CrossRef CAS.
  41. S. Nad and H. Pal, J. Phys. Chem. A, 2003, 107, 501–507 CrossRef CAS.
  42. J. Ye, M. M. Byranvand, C. O. Martínez, R. L. Hoye, M. Saliba and L. Polavarapu, Angew. Chem., Int. Ed., 2021, 60, 21636–21660 CrossRef CAS PubMed.
  43. H. Lee, C. K. Trinh, M. G. So and C.-L. Lee, Nanoscale, 2022, 14, 3425–3440 RSC.
  44. S. Li, D. Lei, W. Ren, X. Guo, S. Wu, Y. Zhu, A. L. Rogach, M. Chhowalla and A. K.-Y. Jen, Nat. Commun., 2020, 11, 1192 CrossRef CAS PubMed.
  45. D. He, X. Xu, Z. Liang, Y. Niu, Y. Sun, T. Gavin, P. Falaras and L. Hu, J. Mater. Chem. C, 2021, 9, 9584–9591 RSC.
  46. V. Gurin, J. Cryst. Growth, 1998, 191, 161–165 CrossRef CAS.
  47. A. Shestha, Y. Yin, G. G. Andersson, N. A. Spooner, S. Qiao and S. Dai, Small, 2016, 13, 1602956 CrossRef PubMed.
  48. M. Zhao, W. Xie and C. Cui, Chem. – Eur. J., 2014, 20, 9259–9262 CrossRef CAS PubMed.
  49. N. A. DeLucia, N. Das and A. K. Vannucci, Org. Biomol. Chem., 2018, 16, 3415–3418 RSC.
  50. P. Asgari, Y. Hua, A. Bokka, C. Thiamsiri, W. Prasitwatcharakorn, A. Karedath, X. Chen, S. Sardar, K. Yum and G. Leem, Nat. Catal., 2019, 2, 164–173 CrossRef CAS PubMed.
  51. A. J. Prochazkova, M. C. Scharber, C. Yumusak, J. Jančík, J. Másilko, O. Brüggemann, M. Weiter, N. S. Sariciftci, J. Krajcovic and Y. Salinas, Sci. Rep., 2020, 10, 15720 CrossRef PubMed.
  52. A. Mehta, J. Im, B. H. Kim, H. Min, R. Nie and S. I. Seok, ACS Nano, 2018, 12, 12129–12139 CrossRef CAS PubMed.
  53. A. Liu, C. Bi, J. Li, M. Zhang, C. Cheng, D. Binks and J. Tian, Nano Lett., 2023, 23, 2405–2411 CrossRef CAS PubMed.
  54. C. Sun, Y. Zhang, C. Ruan, C. Yin, X. Wang, Y. Wang and W. W. Yu, Adv. Mater., 2016, 28, 10088–10094 CrossRef CAS PubMed.
  55. K. Xu, E. T. Vickers, L. Rao, S. A. Lindley, A. L. C. Allen, B. Luo, X. Li and J. Z. Zhang, Chem. – Eur. J., 2019, 25, 5014–5021 CrossRef CAS PubMed.
  56. R. M. Pasternack, S. R. Amy and Y. J. Chabal, Langmuir, 2008, 24, 12963–12971 CrossRef CAS PubMed.

Footnotes

Electronic supplementary information (ESI) available: Fig. S1–S12 and Movies S1–S3. See DOI: https://doi.org/10.1039/d4nr04890c
These authors contributed equally to this work.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.